ℹ️ Compiled from public regulatory records · Last regulator revision: May 22, 2026

Ferrous Fumarate

Iron Bivalent, Oral Preparations

Sold as Integra F

GB MHRAUS FDA

Drug class: Iron Bivalent, Oral Preparations
Availability: Prescription only
Routes: Oral
Markets covered: 2
Products on record: 7
FDA reports (12 mo): 331

B03AAIron Bivalent, Oral Preparations

Overview

Plain-language summary, compiled from the cited regulatory records

Ferrous fumarate is an iron supplement used to treat iron deficiency anemia and folate deficiency anemia [1]. It belongs to the drug class of oral iron bivalent preparations [1].

Ferrous fumarate is approved for use during pregnancy to prevent and treat iron deficiency and to provide a maintenance dosage of folic acid [1]. This active ingredient is available under various brand names, including Integra F [1].

In the past 12 months, there have been 331 adverse event reports associated with ferrous fumarate [2]. The most frequently reported issues include off-label use, nausea, product dose omission, the drug being ineffective, and fatigue [2].

This is not medical advice. Consult a qualified healthcare professional.

Regulatory status by market

Market	Regulator	Products	Last revision
GB United Kingdom	MHRA	6	May 22, 2026
US United States	FDA	1	November 8, 2022

GBUnited Kingdom· MHRA

6 products

Uses

GBOfficial regulatory label· revised April 10, 2026[1]

Prophylaxis and treatment of iron deficiency states. For prophylaxis during pregnancy, a combination of iron and folic acid is usually recommended.

How to take

USUnited States· FDA

1 product

Uses

USOfficial regulatory label· revised November 8, 2022[2]

INDICATIONS:
Integra FTM is indicated for the treatment of iron deficiency anemia, and folate deficiency anemia. Integra FTM is indicated in pregnancy for the prevention and treatment of iron deficiency and to supply a maintenance dosage of folic acid.

How to take

Drug interactions

Known interactions involving Ferrous Fumarate. Select one for details. This list is informational and not a complete interaction checker.

Bictegravir Dimercaprol Dolutegravir Alendronate Aluminum Hydroxide Baloxavir Marboxil Calcium Carbonate Cefdinir Chloramphenicol Cinoxacin Ciprofloxacin Deferiprone Delafloxacin Demeclocycline Dexlansoprazole Doxycycline Eltrombopag Enoxacin Entacapone Esomeprazole Ferric Carboxymaltose Ferric Derisomaltose Ferumoxytol Gatifloxacin Gemifloxacin Grepafloxacin Ibandronate Iron Sucrose Lansoprazole Lanthanum Carbonate Levodopa Levofloxacin Levothyroxine Liothyronine Lomefloxacin Magaldrate Magnesium Carbonate Magnesium Hydroxide Magnesium Oxide Methyldopa Minocycline Moxifloxacin Norfloxacin Ofloxacin Omadacycline Omeprazole Oxytetracycline Pantoprazole Patiromer Penicillamine Quinapril Rabeprazole Risedronic Acid Sarecycline Sodium Bicarbonate Sodium Citrate Sodium Ferric Gluconate Complex Sodium Sulfate Sparfloxacin Tetracycline Tiludronic Acid Trovafloxacin Vitamin E Cimetidine Mycophenolate Mofetil Mycophenolic Acid Zinc Acetate Zinc Gluconate Zinc Sulfate

Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.

Sources & citations

[1]MHRA (UK) · PL127620226 · revised April 10, 2026
[2]FDA DailyMed · 025fee85-53a8-41… · revised November 8, 2022 [PDF]
[3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.